Samsara BioCapital’s Rain Oncology Inc. Common Stock RAIN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-2,034,552
| Closed | -$2.44M | – | 43 |
|
|
2023
Q4 | $2.44M | Hold |
2,034,552
| – | – | 0.38% | 29 |
|
|
2023
Q3 | $1.75M | Hold |
2,034,552
| – | – | 0.54% | 29 |
|
|
2023
Q2 | $2.44M | Sell |
2,034,552
-226,100
| -10% | -$271K | 0.43% | 27 |
|
|
2023
Q1 | $19.8M | Hold |
2,260,652
| – | – | 4.08% | 6 |
|
|
2022
Q4 | $18.1M | Buy |
2,260,652
+700,000
| +45% | +$5.6M | 3.89% | 6 |
|
|
2022
Q3 | $7.62M | Hold |
1,560,652
| – | – | 1.78% | 16 |
|
|
2022
Q2 | $8.68M | Sell |
1,560,652
-10,727
| -0.7% | -$59.6K | 2.31% | 12 |
|
|
2022
Q1 | $7.97M | Hold |
1,571,379
| – | – | 2.01% | 12 |
|
|
2021
Q4 | $20.2M | Hold |
1,571,379
| – | – | 3.93% | 8 |
|
|
2021
Q3 | $23.5M | Sell |
1,571,379
-65,929
| -4% | -$986K | 3.69% | 9 |
|
|
2021
Q2 | $25.4M | Buy |
+1,637,308
| New | +$25.4M | 3.14% | 9 |
|